PCLOF
Price
$0.07
Change
-$0.02 (-22.22%)
Updated
Jan 13 closing price
Capitalization
12.86M
Intraday BUY SELL Signals
ROMJF
Price
$0.36
Change
-$0.00 (-0.00%)
Updated
Jan 13 closing price
Capitalization
24.18M
Intraday BUY SELL Signals
Interact to see
Advertisement

PCLOF vs ROMJF

Header iconPCLOF vs ROMJF Comparison
Open Charts PCLOF vs ROMJFBanner chart's image
PHARMACIELO
Price$0.07
Change-$0.02 (-22.22%)
Volume$21.8K
Capitalization12.86M
Rubicon Organics
Price$0.36
Change-$0.00 (-0.00%)
Volume$77.4K
Capitalization24.18M
PCLOF vs ROMJF Comparison Chart in %
PCLOF
Daily Signal:
Gain/Loss:
ROMJF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PCLOF vs. ROMJF commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCLOF is a Hold and ROMJF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (PCLOF: $0.07 vs. ROMJF: $0.36)
Brand notoriety: PCLOF and ROMJF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PCLOF: 533% vs. ROMJF: 119%
Market capitalization -- PCLOF: $12.86M vs. ROMJF: $24.18M
PCLOF [@Pharmaceuticals: Generic] is valued at $12.86M. ROMJF’s [@Pharmaceuticals: Generic] market capitalization is $24.18M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.17B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCLOF’s FA Score shows that 0 FA rating(s) are green whileROMJF’s FA Score has 0 green FA rating(s).

  • PCLOF’s FA Score: 0 green, 5 red.
  • ROMJF’s FA Score: 0 green, 5 red.
According to our system of comparison, PCLOF is a better buy in the long-term than ROMJF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCLOF’s TA Score shows that 5 TA indicator(s) are bullish while ROMJF’s TA Score has 5 bullish TA indicator(s).

  • PCLOF’s TA Score: 5 bullish, 5 bearish.
  • ROMJF’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both PCLOF and ROMJF are a good buy in the short-term.

Price Growth

PCLOF (@Pharmaceuticals: Generic) experienced а -15.89% price change this week, while ROMJF (@Pharmaceuticals: Generic) price change was -0.61% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.33%. For the same industry, the average monthly price growth was +9.60%, and the average quarterly price growth was +20.12%.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.33% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROMJF($24.2M) has a higher market cap than PCLOF($12.9M). PCLOF YTD gains are higher at: 88.172 vs. ROMJF (3.193). ROMJF has higher annual earnings (EBITDA): 7.29M vs. PCLOF (-4.6M). ROMJF has more cash in the bank: 6.69M vs. PCLOF (257K). ROMJF has less debt than PCLOF: ROMJF (9.32M) vs PCLOF (17.8M). ROMJF has higher revenues than PCLOF: ROMJF (57.2M) vs PCLOF (3.48M).
PCLOFROMJFPCLOF / ROMJF
Capitalization12.9M24.2M53%
EBITDA-4.6M7.29M-63%
Gain YTD88.1723.1932,762%
P/E RatioN/A9.97-
Revenue3.48M57.2M6%
Total Cash257K6.69M4%
Total Debt17.8M9.32M191%
FUNDAMENTALS RATINGS
PCLOF vs ROMJF: Fundamental Ratings
PCLOF
ROMJF
OUTLOOK RATING
1..100
859
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9977
PRICE GROWTH RATING
1..100
3456
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ROMJF's Valuation (55) in the null industry is in the same range as PCLOF (60). This means that ROMJF’s stock grew similarly to PCLOF’s over the last 12 months.

ROMJF's Profit vs Risk Rating (100) in the null industry is in the same range as PCLOF (100). This means that ROMJF’s stock grew similarly to PCLOF’s over the last 12 months.

ROMJF's SMR Rating (77) in the null industry is in the same range as PCLOF (99). This means that ROMJF’s stock grew similarly to PCLOF’s over the last 12 months.

PCLOF's Price Growth Rating (34) in the null industry is in the same range as ROMJF (56). This means that PCLOF’s stock grew similarly to ROMJF’s over the last 12 months.

PCLOF's P/E Growth Rating (100) in the null industry is in the same range as ROMJF (100). This means that PCLOF’s stock grew similarly to ROMJF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PCLOFROMJF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 10 days ago
74%
Bullish Trend 2 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
PCLOF
Daily Signal:
Gain/Loss:
ROMJF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GUER2.210.03
+1.28%
Guerrilla RF, Inc.
FBSFF16.96N/A
N/A
Fabasoft AG
PWFNF16.03N/A
N/A
Power Financial Corp.
DPLMF74.65N/A
N/A
Diploma Plc.
AVSFY22.66N/A
N/A
Avi Ltd.

PCLOF and

Correlation & Price change

A.I.dvisor tells us that PCLOF and OWPC have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCLOF and OWPC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCLOF
1D Price
Change %
PCLOF100%
-18.60%
OWPC - PCLOF
8%
Poorly correlated
+2.86%
PHCUF - PCLOF
7%
Poorly correlated
N/A
RGEDF - PCLOF
5%
Poorly correlated
N/A
OVATF - PCLOF
4%
Poorly correlated
N/A
ROMJF - PCLOF
3%
Poorly correlated
+0.30%
More

ROMJF and

Correlation & Price change

A.I.dvisor tells us that ROMJF and SGIOF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ROMJF and SGIOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROMJF
1D Price
Change %
ROMJF100%
+0.30%
SGIOF - ROMJF
8%
Poorly correlated
N/A
SGIOY - ROMJF
8%
Poorly correlated
-2.47%
TEVJF - ROMJF
4%
Poorly correlated
N/A
PCLOF - ROMJF
3%
Poorly correlated
-18.60%
OMID - ROMJF
2%
Poorly correlated
N/A
More